ANGLE PLC’s (LON:AGL) (OTCQX:ANPCY) ground-breaking liquid biopsy system will be incorporated into a clinical study to provide an early warning of relapse among patients being treated for non-small cell lung cancer. The Partsortix system will be used in research being carried out by the Hellenic Oncology Research Group and will be deployed to track circulating tumour DNA, fragments of dead cancer cells and circulating tumour cells (CTCs).
Arc Minerals Ltd (LON:ARCM) has kicked off its exploration programme at the Zamsort project in north-western Zambia. Infill soil sampling has commenced over the new target areas, and 1,200 samples have already been grabbed.
Oil and gas rig contractor ADES International Holding PLC (LON:ADES) has secured two onshore contracts in Algeria with state-owned oil group Sonatrach. The ADES 2 contract comprises one firm well and four optional wells worth up to US$8mln in total.
Life sciences group Integumen PLC (LON:SKIN) has agreed to buy scientific data management specialist RinoCloud for £3mln as it looks to build out its Labskin AI platform. AIM-quoted Integumen had been using RinoCloud’s technology in its development of Labskin AI – an extension of Integumen’s laboratory-grown skin product which provides real-time test results to skincare, wound care, pharma, healthcare and personal care companies.
AFC Energy PLC (LON:AFC), the alkaline fuel cell power company, has raised money through a share subscription and entered into a convertible bond facility. The company has conditionally raised £813,000 before expenses by way of a subscription for 27.1mln shares at 3p a pop; AFC’s shares closed at 3.775p last night.
Europa Oil & Gas Holdings PLC (LON:EOG) is looking forward to a potential third-party exploration catalyst offshore Ireland, with China’s CNOOC due to drill a well to test the Iolar prospect. Exploration success in the South Porcupine basin would be significant for all companies with interests in Ireland’s Atlantic frontier, while for Europa it would specifically benefit the Kiely East (estimated at 280mln barrels) and the Edgeworth (225mln barrel) targets.
Yellow Cake PLC (LON:YCA) is raising £25.9mln, increased from £22.9mln, through a share placing in order to fund the purchase of at least 1mln pounds of uranium. The company, a vehicle specifically set up to acquire and own physical uranium as an investment strategy, upgraded the funding after the original offer (announced yesterday) saw strong investor demand.
African Battery Metals PLC (LON:ABM) has announced the recommencement of exploration activities at its Kisinka Copper-Cobalt project in the Democratic Republic of Congo with immediate effect following a detailed review of historic exploration.
Rose Petroleum PLC (LON:ROSE), the AIM-quoted natural resources business announced that, on 11 April, Matthew Idiens, its chief executive officer purchased 2,000,000 ordinary shares in the company at an average price of 1.75p each, taking his holding up to 2.52% of the existing ordinary share capital. The group added that, on the same date, its chief financial officer Chris Eadie purchased 945,600 ordinary shares at an average price of 1.67p each taking his holding to 1.20%. In addition, it said, Tom Reynolds, a proposed non-executive director of the group purchased 731,694 ordinary shares at an average price of 1.715p each also on 11 April.
WideCells Group PLC (LON:WDC) has announced that, European High Growth Opportunities Securitization Fund has transferred to Linton Capital LLP - a limited liability partnership which is controlled by its executive chairman David Sefton - 35,356,580 ordinary shares in the company. The group said Sefton and Linton Capital have agreed that the ordinary shares held by Linton shall be subject to a 12 month lock-in terms followed by a 12 month orderly market undertaking. In a separate statement, Widecells was notified that European High Growth Opportunities Securitization Fund’s holding in the company has been reduced to 18.17%, down from 22.64% previously.
IXICO PLC (LON: IXI), the data analytics company delivering insights in neuroscience, has announced the appointment, with immediate effect, of Cenkos Securities as its nominated adviser and sole broker.